Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite

Kenneth T. Bogen, Lora L Arnold, Aparajita Chowdhury, Karen L. Pennington, Samuel Monroe Cohen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability (%), estimated as 100% times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1–P–Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10−5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100% significance (p ≤ 10−6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.

Original languageEnglish (US)
Pages (from-to)32-38
Number of pages7
JournalToxicology Reports
Volume4
DOIs
StatePublished - Jan 1 2017

Fingerprint

Keratinocytes
Assays
Cell Survival
Cells
Cytotoxicity
arsenite
Cell Line

Keywords

  • Arsenate
  • Arsenic
  • Cell culture
  • Cell death
  • Cytotoxicity
  • HEK001 cells

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite. / Bogen, Kenneth T.; Arnold, Lora L; Chowdhury, Aparajita; Pennington, Karen L.; Cohen, Samuel Monroe.

In: Toxicology Reports, Vol. 4, 01.01.2017, p. 32-38.

Research output: Contribution to journalArticle

@article{254eb0d270104dc48d0250dd97ae649d,
title = "Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite",
abstract = "The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability ({\%}), estimated as 100{\%} times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1–P–Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10−5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100{\%} significance (p ≤ 10−6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.",
keywords = "Arsenate, Arsenic, Cell culture, Cell death, Cytotoxicity, HEK001 cells",
author = "Bogen, {Kenneth T.} and Arnold, {Lora L} and Aparajita Chowdhury and Pennington, {Karen L.} and Cohen, {Samuel Monroe}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.toxrep.2016.12.003",
language = "English (US)",
volume = "4",
pages = "32--38",
journal = "Toxicology Reports",
issn = "2214-7500",
publisher = "Elsevier Scientific Publishers Ireland",

}

TY - JOUR

T1 - Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite

AU - Bogen, Kenneth T.

AU - Arnold, Lora L

AU - Chowdhury, Aparajita

AU - Pennington, Karen L.

AU - Cohen, Samuel Monroe

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability (%), estimated as 100% times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1–P–Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10−5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100% significance (p ≤ 10−6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.

AB - The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability (%), estimated as 100% times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1–P–Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10−5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100% significance (p ≤ 10−6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.

KW - Arsenate

KW - Arsenic

KW - Cell culture

KW - Cell death

KW - Cytotoxicity

KW - HEK001 cells

UR - http://www.scopus.com/inward/record.url?scp=85006964937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006964937&partnerID=8YFLogxK

U2 - 10.1016/j.toxrep.2016.12.003

DO - 10.1016/j.toxrep.2016.12.003

M3 - Article

C2 - 28959622

AN - SCOPUS:85006964937

VL - 4

SP - 32

EP - 38

JO - Toxicology Reports

JF - Toxicology Reports

SN - 2214-7500

ER -